Patents
Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632)
09/2010
09/29/2010CN101845090A Rat RANK extracellular protein crystal
09/29/2010CN101844097A Shredder with gas detection system
09/29/2010CN101843895A Cytokine receptor ZCYTOR17 multimers
09/29/2010CN101843632A Application of miR-145 in preparing medicament for treating inflammation
09/29/2010CN101581669B Photobleaching-based method for quantitatively measuring fluorescence resonance energy efficiency
09/29/2010CN101576550B Evaluation device and evaluation method for scale formation trend and scale inhibition effect
09/29/2010CN101508977B Separation identification and purification process for chicken source H9N2 avian influenza virus strain and uses thereof
09/29/2010CN101446580B Method for determining inherent chemical components of traditional Chinese medicinal material
09/29/2010CN101446529B Field measurement system of wall rock mechanical parameter
09/29/2010CN101329227B Liver perfusion method for small-sized animals liver lymphocyte separation
09/29/2010CN101323611B Polar sensitive fluorescent probe compounds for arginine residue marker, preparation and use thereof
09/29/2010CN101220096B Preparation and application of humanized anti-spasmotoxin monoclone antibody
09/29/2010CN101196447B Washing method and device for biological chip
09/29/2010CN101147623B Cigarette supplementary lean combined assembling method
09/29/2010CN101131361B Cell for conducting electrochemiluminescence measurements and its uses
09/29/2010CN101086473B Reagent for sample analysis, kit for sample analysis and method for sample analysis
09/29/2010CN101070345B Anti-prostate-specific-antigen PSA monoclone antibody and its use
09/29/2010CN101059493B On-line biosafety pre-alarming method for water quality
09/29/2010CN101008639B Method and device for accurate testing of petroleum products pour point
09/29/2010CN101008638B Method and device for accurate testing of petroleum products questionable points
09/28/2010US7805438 Learning a document ranking function using fidelity-based error measurements
09/28/2010US7805396 Computerized identification of normal and abnormal diurnal cortisol secretion patterns and levels of testosterone from human saliva samples
09/28/2010US7805282 Process, software arrangement and computer-accessible medium for obtaining information associated with a haplotype
09/28/2010US7805253 Methods and systems for discovering protein modifications and mutations
09/28/2010US7804592 using a noble metal compound having N,N,N'-tri(2-pyridylmethyl)-N'-[5-N''-(2-aminoethyl)carbamoyl-2-pyridylmethyl]-1,3-diamino-propane-2-ol zinc complex as substituent for detecting phosphorylation of peptide in a sample; Raman spectroscopy
09/28/2010US7803982 Recombinant rodent comprising mutant g protein coupled receptor for use in identifying modulators of taste; artificial sweetners; flavoring
09/28/2010US7803936 Compounds and methods for labeling oligonucleotides
09/28/2010US7803933 siRNA targeting TATA box binding protein (TBP)-associated factor (TAF1)
09/28/2010US7803923 Growth differentiation factor-8 binding agents for treatment of metabolic, nervous system, muscular, bone , urogenital and inflammatory disorders; for treating muscle-wasting disorders and metabolic disorders including diabetes and obesity
09/28/2010US7803918 gene delivery vehicle comprising the isolated and/or recombinant nucleic acid sequence; methods for typing the virus in various samples and diagnosing of disease
09/28/2010US7803909 Truncated tyrosine kinase for use in identifying modulators for prevention and treatment of cell proliferative disorders
09/28/2010US7803788 Phosphoramidate linkages; retroviral or hepadnaviral therapy; tissue targeted therapy; HIV/aquired immunodeficiency syndrome; antitumor agents; improved bioavailability
09/28/2010US7803774 retro-inverso isomers of beta-amyloid peptides, used for diagnosis and treatment of amyloidogenic diseases such as Alzheimer's disease
09/28/2010US7803765 production and of nucleic acid fragment libraries that express highly diverse peptides, polypeptides or protein domains and, in particular, nucleic acid fragment libraries wherein the nucleic acid fragments are derived from two or more prokaryote genomes or compact eukaryote genomes
09/28/2010US7803758 I kappa B kinase complex as a target for the treatment of Huntington's disease
09/28/2010US7803739 Substrates and assays for β-secretase
09/28/2010US7803638 hydrophilic polymer from 3-sulfopropyl methacrylate, with phosphor containing indacene derivative bound via ethylene oxide-propylene oxide derivative; immunoassay; antibody and antigen detection
09/28/2010US7803636 Apparatus comprising zoned matrix for use in screening fluids for human chorionic gonadotropin, leutenizing hormone, follicle stimulating hormone, specific and non-specific proteins, blood or blood components, antibodies, drugs and drugs of abuse, urea, nitrite and glutaraldehye; colorimetric analysis
09/28/2010US7803633 Screening arrangement for screening immunoassay tests and agglutination tests
09/28/2010US7803631 Process and arrangement for determining water content
09/28/2010US7803630 Method for detecting target compounds containing sulfenic acids using new reagents
09/28/2010US7803629 test includes molecular weight distribution (MWD) profile and a short chain branching distribution (SCBD); rapid and cheap
09/28/2010US7803628 including a measuring chamber through which the medium can flow and which has at least one elastically deformable wall, at least one wall that is more rigid by comparison to the elastically deformable wall, and an inlet and outlet for the medium, an excitation electrode is provided
09/28/2010US7803627 Process for evaluating quality of coke and bitumen of refinery feedstocks
09/28/2010US7803625 Method for determining the fatty acid profile of milk by infrared spectroscopy
09/28/2010US7803624 Using biopolymer sensors to identify and screen histological tissues; diagnosing cell proliferative disorders; high throughput assay
09/28/2010US7803614 isolated host cell transfected with the recombinant expression vector encoding an immunogenic protein; diagnosis of skin cancer; vaccine for prevent and treatment; immunotherapy
09/28/2010US7803595 Mammalian sphingosine kinase type 2 isoforms, cloning, expression and methods of use thereof
09/28/2010US7803579 Strand displacement amplification is used to synthesize a nucleic acid having a sequence complementary to a target sequence by using a primer designed so that it is capable of forming a stem-loop structure by the extension of the primer and satisfies additional specific requirements
09/28/2010US7803572 Contacting a sample solution with a protease substrate labeled with an electrochemically active metallocene marker; providing conditions under which protease may degrade the protease substrate; and electrochemically determining information relating to the marker to detect protease activity; diagnosis
09/28/2010US7803570 Method for determining the concentration of thrombin inhibitors
09/28/2010US7803569 Atherothrombosis risk in an individual is indicated by an FSAP protein concentration that is reduced compared to the FSAP protein concentration in the standard sample
09/28/2010US7803568 Carbodithioate ligands for nanotechnology and biosensing applications
09/28/2010US7803567 Contacting a fixed sample such as a pap smear with a monoclonal antibody produced from the hybridoma cell line HA423 that specifically binds a fixed Trichomonas alpha actinin antigen and detecting the complex formed; diagnosis
09/28/2010US7803566 Identifying T-cells in a sample that become activated in the presence of an amino acid sequence of a peptide with the same function as a CD8 T cell epitope of a vaccinia or variola virus; diagnosing vaccinia or variola virus infection by determining if the T-cells are activated by the peptide
09/28/2010US7803565 Use of lymphocytes to measure anthrax lethal toxin activity
09/28/2010US7803564 EGF-like nucleic acids and polypeptides and uses thereof
09/28/2010US7803563 Method for screening the receptor-ligand binding in live cell
09/28/2010US7803562 Method for screening human intestinal Npt2B modulatory agents
09/28/2010US7803561 Using g-protein coupled receptor 30 (GPR30) cell surface concentration as diagnostic indicator of metastatic endrocrine disorders
09/28/2010US7803560 Contacting a candidate antagonist with a MCP-1 receptor polypeptide having an amino acid sequence at least 95% homologous to an extracellular domain of a specific sequence, and comparing the binding of MCP-1 to the receptor polypeptide; decreased binding indicates an antagonist
09/28/2010US7803559 Protein aggregation regulators
09/28/2010US7803558 Screening for a substance that inhibits VE-cadherin protein adhesion between Schlemm's canal cells by culturing the cells on a plate containing of all of the extracellular domain of VE-cadherin in the presence of the substance and measuring adhesion; reduced adhesion indicates a good candidate
09/28/2010US7803557 Screening a candidate compound for antiinflammatory activity by administering the candidate in vivo to cells of an animal that express a Reso E receptor; reduced expression of interleukin-12 and reduced migration of dendritic cells into T-cell areas of the spleen indicates a good candidate
09/28/2010US7803556 Using adiponectin receptor to identify modulators for prevention and treatment of obesity
09/28/2010US7803555 Determining the effect of a test compound on the binding interaction between a folate receptor and a folate receptor-binding fragment of a filovirus envelope glycoprotein; a compound that reduces binding is a candidate compound for slowing the progression of a filovirus, e.g., Ebola, mediated disease
09/28/2010US7803554 Using fluorescein probe as diagnostic tool in monitoring biopolymer complexes; quantitation of binding factors with fluorescence techniques; identifying mutation and disease diagnosis
09/28/2010US7803553 Detecting the activation reactions of human transforming growth factor- beta 1, 2, and/or 3 in samples by staining or reacting the sample with an antibody against a latency-associated peptide fragment of human TGF- beta , that recognizes a protease cleavage site; diagnosing sclerotic diseases
09/28/2010US7803552 Biomarkers for predicting prostate cancer progression
09/28/2010US7803546 Method of screening for sensitivity to kinase inhibitor therapy
09/28/2010US7803533 Diagnostic agent for malignant melanoma
09/28/2010US7803532 Diagnosis of Sezary syndrome (a type of lymphoma) by analyzing a nucleic acid sample from a human patient to detect the presence or the absence of a neuron navigator 3 gene and diagnosing Sezary syndrome when the gene is absent
09/28/2010US7803524 Diagnostic compositions containing the polypeptide conjugated to a detectable label, such as radioisotopes, enzymes, fluorescent labels, antibody conjugates, or substrates
09/28/2010US7803379 Tumour-specific animal proteins
09/28/2010US7803377 Anti-DLL4 antibodies and methods using same
09/28/2010US7803373 Chemokine panec-1 antibodies
09/28/2010US7803370 Method for treating synovial sarcoma
09/28/2010US7803361 Decreasing solid tumor size in a cancer patient by administering an interleukin-2 mutant with reduced vasopermeability activity compared to a wildtype form, and being Arg38Trp, wherein said wildtype form is human IL-2 mutant and the IL-2 mutant is not linked to an antibody.
09/28/2010US7803323 System and method for cleaning in-process sensors
09/28/2010US7803322 Optical reading system, a universal testing cartridge, coupling optical reading systems, medical diagnostics
09/28/2010US7803318 portable medical equipment for the determination of blood glucose levels; the positioning of the drum cartridge in its working position and the closing of the lid is combined into a single handling step
09/28/2010US7803123 Lancet device having capillary action
09/28/2010US7802477 Oral sensation measuring device for foods
09/28/2010US7802467 Analyte sensors and methods of use
09/28/2010CA2574417C Timp-2 as target/marker of beta cell failure
09/28/2010CA2567675C System and method for analysing a sample liquid
09/28/2010CA2544185C Method of detecting hepatitis c virus
09/28/2010CA2494671C Composition and method for reducing the rate of oxygen loss from aqueous solutions
09/28/2010CA2488427C Rapid diagnosis device with locking by test strip
09/28/2010CA2478993C Detecting interactions at biomimetic interfaces with liquid crystals
09/28/2010CA2449511C Point-of-care in-vitro blood analysis system
09/28/2010CA2415493C Cation mediated triplex hybridization assay
09/28/2010CA2407726C Sulfonated [8,9]benzophenoxazine dyes and the use of their labelled conjugates
09/28/2010CA2387016C Acrylamide derivatives as fab i inhibitors
09/28/2010CA2327414C Immunoassay of human medullasin and diagnosis of multiple sclerosis using the same
09/28/2010CA2326821C Nucleic acid encoding hyaluronan synthase and methods of use
09/28/2010CA2286288C Monoclonal antibody recognizing the n-glycolylated-galacotose-glucose sialic acid oligosaccharide in malignant tumors and composition that contains it
09/28/2010CA2285746C Osteoprotegerin binding proteins and receptors
09/28/2010CA2235866C Methods of treating established colitis using antibodies against il-12
09/28/2010CA2188017C Cardiotrophin and uses therefor